Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C MutationFerdinandos Skoulidis, Ramaswamy Govindan, Bob T. Li et al.|New England Journal of Medicine|2021Cited by 1.8k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung CancerAlexander Drilon, Vivek Subbiah, Philippe A. Cassier et al.|New England Journal of Medicine|2020Cited by 835
Programmed death ligand-1 expression in non-small cell lung cancerVamsidhar Velcheti, David L. Rimm, Kurt A. Schalper et al.|Laboratory Investigation|2013Cited by 753
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancerArvind Ravi, Justin F. Gainor, Matthew D. Hellmann et al.|Nature Genetics|2023Cited by 185
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancerXinyuan Tong, Hongbin Ji, Ayushi S. Patel et al.|Cancer Cell|2024Cited by 115